GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Millennium Pharmacon International Tbk (ISX:SDPC) » Definitions » Revenue

PT Millennium Pharmacon International Tbk (ISX:SDPC) Revenue : Rp3,923,319 Mil (TTM As of Mar. 2025)


View and export this data going back to 1990. Start your Free Trial

What is PT Millennium Pharmacon International Tbk Revenue?

PT Millennium Pharmacon International Tbk's revenue for the three months ended in Mar. 2025 was Rp980,187 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2025 was Rp3,923,319 Mil. PT Millennium Pharmacon International Tbk's Revenue per Share for the three months ended in Mar. 2025 was Rp769.38. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was Rp3,079.53.

During the past 12 months, the average Revenue per Share Growth Rate of PT Millennium Pharmacon International Tbk was 9.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, PT Millennium Pharmacon International Tbk's highest 3-Year average Revenue per Share Growth Rate was 16.10% per year. The lowest was -9.60% per year. And the median was 8.40% per year.


PT Millennium Pharmacon International Tbk Revenue Historical Data

The historical data trend for PT Millennium Pharmacon International Tbk's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Millennium Pharmacon International Tbk Revenue Chart

PT Millennium Pharmacon International Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,643,626.51 2,988,848.57 3,200,833.10 3,363,517.81 3,916,863.88

PT Millennium Pharmacon International Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 973,732.36 966,552.75 983,825.88 992,752.89 980,187.38

Competitive Comparison of PT Millennium Pharmacon International Tbk's Revenue

For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Millennium Pharmacon International Tbk's Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Millennium Pharmacon International Tbk's Revenue distribution charts can be found below:

* The bar in red indicates where PT Millennium Pharmacon International Tbk's Revenue falls into.


;
;

PT Millennium Pharmacon International Tbk Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp3,923,319 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Millennium Pharmacon International Tbk  (ISX:SDPC) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


PT Millennium Pharmacon International Tbk Revenue Related Terms

Thank you for viewing the detailed overview of PT Millennium Pharmacon International Tbk's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Millennium Pharmacon International Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, Selatan, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The operating segments of the group are Prescription medicine, Non-prescription medicine, and Medical devices, of which the majority of the revenue is derived from the Prescription Medicine segment.. The company's geographical segments are Java, Sumatera, Kalimantan, Sulawesi, and Bali.

PT Millennium Pharmacon International Tbk Headlines

No Headlines